HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased in vivo immunological potency of HB-110, a novel therapeutic HBV DNA vaccine, by electroporation.

Abstract
Pulse-induced permeabilization of cellular membranes, generally referred to as electroporation (EP), has been used for years as a tool to increase macromolecule uptake in tissues, including nucleic acids, for gene therapeutic applications, and this technique has been shown to result in improved immunogenicity. In this study, we assessed the utility of EP as a tool to improve the efficacy of HB-110, a novel therapeutic DNA vaccine against chronic hepatitis B, now in phase 1 of clinical study in South Korea. The potency of HB-110 in mice was shown to be improved by EP. The rapid onset of antigen expression and higher magnitude of humoral and cellular responses in electric pulse-treated mice revealed that EP may enable a substantial reduction in the dosage of DNA vaccine required to elicit a response similar in magnitude to that achievable via conventional administration. This study also showed that EP-based vaccination at 4-week-intervals elicited a cellular immune response which was about two-fold higher than the response elicited by conventional vaccination at 2-week intervals. These results may provide a rationale to reduce the clinical dose and increase the interval between the doses in the multidose vaccination schedule. Electric pulsing also elicited a more balanced immune response against four antigens expressed by HB-110: S, preS, Core, and Pol.
AuthorsChae Young Kim, Eun Sung Kang, Seon Beom Kim, Han Eol Kim, Jae Hoon Choi, Dong Sop Lee, Se Jin Im, Se Hwan Yang, Young Chul Sung, Byong Moon Kim, Byung Gee Kim
JournalExperimental & molecular medicine (Exp Mol Med) Vol. 40 Issue 6 Pg. 669-76 (Dec 31 2008) ISSN: 1226-3613 [Print] United States
PMID19116452 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hepatitis B Antigens
  • Hepatitis B Vaccines
  • Vaccines, DNA
Topics
  • Animals
  • Electroporation
  • Hepatitis B Antigens (biosynthesis)
  • Hepatitis B Vaccines (administration & dosage, immunology)
  • Hepatitis B, Chronic (immunology, prevention & control)
  • Immunity, Cellular
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Vaccines, DNA (administration & dosage, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: